-logo.jpg "ResMed Inc. (CHESS) logo")
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
- Sub-Industry: N/A
- Symbol: ASX:RMD
- CUSIP: N/A
- Web: www.resmed.com
Average Prices:- 50 Day Moving Avg: A$9.60
- 200 Day Moving Avg: A$9.49
P/E:- Trailing P/E Ratio: 41.25
- P/E Growth: 2.42
Dividend:
Frequently Asked Questions for ResMed Inc. (CHESS) (ASX:RMD)
What is ResMed Inc. (CHESS)'s stock symbol?
ResMed Inc. (CHESS) trades on the ASX under the ticker symbol "RMD."
Who are some of ResMed Inc. (CHESS)'s key competitors?
Some companies that are related to ResMed Inc. (CHESS) include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Shire PLC (SHP), Illumina (ILMN), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), Bio-Rad Laboratories (BIO), Valeant Pharmaceuticals Intl (VRX), NMC Health PLC (NMC), ConvaTec Group PLC (CTEC), Health Net (HNT), Patheon NV (PTHN), Mediclinic International PLC (MDC), Catalent (CTLT), Taro Pharmaceutical Industries (TARO) and Puma Biotechnology (PBYI).
Who are ResMed Inc. (CHESS)'s key executives?
ResMed Inc. (CHESS)'s management team includes the folowing people:
- Rob Douglas, President, Chief Operating Officer
- Michael Farrell, Chief Executive Officer, Director
- Brett A. Sandercock, Chief Financial Officer
- Jim Hollingshead Ph.D., President - Americas
- Anne Reiser, President – Europe & Asia Pacific
- David Pendarvis, Chief Administrative Officer, Global General Counsel, Company Secretary
- Agnes Lee, Senior Director - Investor Relations
- Peter C. Farrell Ph.D., Non-Executive Chairman of the Board
- Ronald R. Taylor, Lead Independent Director
- Carol J. Burt, Independent Director
MarketBeat Community Rating for ResMed Inc. (CHESS) (ASX RMD)MarketBeat's community ratings are surveys of what our community members think about ResMed Inc. (CHESS) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for ResMed Inc. (CHESS) (ASX:RMD) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for ResMed Inc. (CHESS) (ASX:RMD)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for ResMed Inc. (CHESS) (ASX:RMD)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for ResMed Inc. (CHESS) (ASX:RMD)No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for ResMed Inc. (CHESS) (ASX:RMD)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for ResMed Inc. (CHESS) (ASX:RMD)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for ResMed Inc. (CHESS) (ASX:RMD)
Latest Headlines for ResMed Inc. (CHESS) (ASX:RMD)
| Source: |
|
| Date | Headline |
|---|
 | 2 healthcare shares to consider if you're new to investing - Motley Fool Australia
www.fool.com.au - September 19 at 7:14 AM |
 | ETFs with exposure to ResMed, Inc. : August 25, 2017
finance.yahoo.com - August 26 at 8:54 AM |
| See what the IHS Markit Score report has to say about ResMed Inc.
finance.yahoo.com - August 13 at 5:54 AM |
| ResMed, Inc. :RMD-AU: Earnings Analysis: Q4, 2017 By the Numbers : August 9, 2017
finance.yahoo.com - August 10 at 7:29 AM |
| ResMed, Inc. :RMD-AU: Earnings Analysis: 2017 By the Numbers : August 8, 2017
finance.yahoo.com - August 9 at 6:57 AM |
| 3 family-run ASX companies for your investing watchlist - Motley Fool Australia
www.fool.com.au - August 4 at 7:39 AM |
| 5 reasons to buy ResMed Inc (CHESS) shares today - Motley Fool Australia
www.fool.com.au - August 4 at 7:39 AM |
| ResMed (RMD) Q4 Earnings Top, 2020 Strategic Goals on Track
finance.yahoo.com - August 2 at 3:57 PM |
| Want quarterly dividends? Buy these 4 stocks
www.fool.com.au - July 11 at 7:08 AM |
| Why the Compumedics Limited share price fell 19% today - Motley Fool Australia
www.fool.com.au - July 8 at 2:05 PM |
| Why Is ResMed (RMD) Down 3.8% Since the Last Earnings Report?
finance.yahoo.com - May 31 at 12:47 PM |
| Attention: These 3 healthcare shares are powering the S&P/ASX 200 to new highs - Motley Fool Australia
www.fool.com.au - May 29 at 6:32 PM |
| 2 healthcare shares with dividend yields over 6.5% - Motley Fool Australia
www.fool.com.au - May 29 at 12:59 AM |
| Is Your Portfolio Diversified? - Motley Fool Australia
www.fool.com.au - May 29 at 12:59 AM |
| Record profits: Is Fisher & Paykel Healthcare Corp Ltd still a buy? - Motley Fool Australia
www.fool.com.au - May 23 at 6:58 PM |
| Big Data Yields Big Insights for Treatment of Central Sleep Apnea
finance.yahoo.com - May 22 at 9:19 AM |
| Statement by ResMed on Plans to Renew Its Patent Infringement Case Against Fisher & Paykel
finance.yahoo.com - May 17 at 5:31 AM |
| Introducing the Softest CPAP Mask from ResMed
finance.yahoo.com - May 16 at 9:31 AM |
| ETFs with exposure to ResMed, Inc. : May 11, 2017
finance.yahoo.com - May 11 at 8:02 PM |
| ResMed, Inc. :RMD-AU: Earnings Analysis: Q3, 2017 By the Numbers : May 8, 2017
finance.yahoo.com - May 9 at 10:46 AM |
| Acquisitions Help Drive ResMed's Revenue 13% Higher
finance.yahoo.com - May 1 at 10:13 AM |
| ResMed (RMD) Beats Q3 Earnings, Misses Sales Estimates
finance.yahoo.com - April 28 at 3:37 PM |
| Why ResMed Inc (CHESS) still offers investors big potential
www.fool.com.au - April 27 at 8:00 PM |
| Here are 3 shares on the S&P/ASX 100 I would buy today - Motley Fool Australia
www.fool.com.au - April 10 at 7:06 PM |
| Here are 3 quality shares on the S&P/ASX 100 that I would buy today
www.fool.com.au - April 4 at 5:11 AM |
| ASX preview on Thursday: 9 shares you need to watch today - Motley Fool Australia
www.fool.com.au - March 9 at 7:33 PM |
| ASX 200 rebounds on Tuesday: 9 shares you should have been watching
www.fool.com.au - January 24 at 12:55 AM |
| ResMed Q2 profit down but revenue up
au.finance.yahoo.com - January 24 at 12:55 AM |
| BlueScope, ResMed news boosts share market
au.finance.yahoo.com - January 24 at 12:55 AM |
| Why it’s time to wake up to ResMed Inc.’s (CHESS) potential
www.fool.com.au - January 23 at 7:54 PM |
| Why the Australian Dollar is skyrocketing toward US75 cents - Motley Fool Australia
www.fool.com.au - January 13 at 1:18 AM |
| ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders
finance.yahoo.com - January 9 at 8:49 AM |
| Debt Binge: Is this why the CSL Limited share price is plunging? - Motley Fool Australia
www.fool.com.au - December 12 at 9:27 AM |
| 3 ASX stocks to buy now to get rich later
www.fool.com.au - October 20 at 8:33 AM |
| 4 growth shares I can’t help but love
www.fool.com.au - October 13 at 10:48 AM |
| 4 ASX shares to help you to an early retirement
www.fool.com.au - September 29 at 12:13 PM |
| 3 growth shares I’d buy with $10,000 today
www.fool.com.au - September 16 at 6:50 PM |
| 3 blue-chip shares that won’t let you down
www.fool.com.au - September 10 at 6:17 PM |
 | ResMed (RMD) Stock Slides, Jefferies Downgrades to 'Underperform'
www.thestreet.com - August 23 at 7:18 PM |
| Look at Medical Product Earnings on Jul 28: BSX, RMD & More
finance.yahoo.com - July 27 at 6:59 AM |
| The easy way to start building a $1 million share portfolio in FY 2017
www.fool.com.au - July 20 at 10:00 AM |
| ResMed books mixed third-quarter results
au.finance.yahoo.com - April 26 at 8:45 PM |
| ResMed Q3 revenue up 7 pct
au.finance.yahoo.com - April 26 at 7:42 PM |
| ResMed: Strong Cash Balance, Product Portfolio Drive Growth
finance.yahoo.com - April 8 at 2:50 PM |
| ResMed (RMD) Stock Gets 'Underweight' Rating at Barclays
www.thestreet.com - April 7 at 9:17 AM |
 | ResMed (RMD) Announces Completion of Inova Labs Acquisition
www.streetinsider.com - February 4 at 2:36 PM |
| Why AGL Energy Ltd & Fisher & Paykel Healthcare Corp Ltd could offer growth & income
www.fool.com.au - February 3 at 7:19 PM |
 | ResMed Inc. (RMD) Jumped To A 6-Week High On Strong Q2 Earnings
www.rttnews.com - January 25 at 1:15 PM |
| Why ResMed Inc's Stock Is Up Big Today
www.fool.com - January 22 at 12:17 PM |
| Resmed lifts 2Q revenue 7% to $US454.5m
au.finance.yahoo.com - January 21 at 5:50 PM |
